Investigative Ophthalmology & Visual Science Cover Image for Volume 61, Issue 7
June 2020
Volume 61, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2020
Comparing Clinic Efficiency of Hydroxychloroquine Tele-Retinal Screenings in a Large Public Safety Net Hospital Setting
Author Affiliations & Notes
  • Hong-Uyen Hua
    Ophthalmology, USC Roski Eye Institute, Los Angeles, California, United States
  • Betty Situ
    Ophthalmology, USC Roski Eye Institute, Los Angeles, California, United States
  • Abdul-Hadi Kaakour
    Ophthalmology, USC Roski Eye Institute, Los Angeles, California, United States
  • Brian C Toy
    Ophthalmology, USC Roski Eye Institute, Los Angeles, California, United States
  • Footnotes
    Commercial Relationships   Hong-Uyen Hua, None; Betty Situ, None; Abdul-Hadi Kaakour, None; Brian Toy, None
  • Footnotes
    Support  RPB
Investigative Ophthalmology & Visual Science June 2020, Vol.61, 1584. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Hong-Uyen Hua, Betty Situ, Abdul-Hadi Kaakour, Brian C Toy; Comparing Clinic Efficiency of Hydroxychloroquine Tele-Retinal Screenings in a Large Public Safety Net Hospital Setting. Invest. Ophthalmol. Vis. Sci. 2020;61(7):1584.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Hydroxychloroquine (HCQ) retinopathy is a major long-term side effect of HCQ, and risk of toxicity is decreased with appropriate dosing and timely screening. However, over half of patients on HCQ may not receive appropriate screening. We perform a retrospective chart review to determine whether hydroxychloroquine teleretinal screenings decrease time-to-appointment and time-in-clinic in a large public county safety net hospital setting.

Methods : The study was approved by the USC Institutional Review Board. Patients with active HCQ prescription orders and most recent ophthalmology visit at LAC+USC from 11/1/2018 to 11/25/2019 were identified by an electronic medical record query (n=544). Patients who underwent teleretinal screening (n=207) were excluded from this list to identify a convenience sample of 54 patients who underwent regular clinic screening (n=380). Demographic characteristics, most recent weight, known risk factors, and dates for clinic visits, HCQ prescription orders, and ophthalmology eConsult requests were recorded. Time-to-appointment and time-in-clinic were compared between teleretinal screening and regular screening with Student’s t-test.

Results : 88.7% of the regular clinic screening (RCS) population, and 90.7% of the teleretinal screening (TRS) population was female. Indications for hydroxychloroquine included most commonly lupus (22% in the RCS group, and 38.5% in the TRS group) and rheumatoid arthritis (48.1% in the RCS group, 41.5% in the TRS group). Patients in TRS experienced a significantly decreased latency between eConsult request and a scheduled appointment for screening compared with for patients in RCS (3.19 months vs 5.28 months, p < 0.001). Average total time of appointment was also significantly different: 69 minutes for TRS compared to 180.4 min RCS (p=0.006).

Conclusions : In our two patient cohorts who undergo teleretinal screening vs regular clinic screening, we demonstrate that teleretinal screening patients may benefit from decreased wait time from initial ophthalmology eConsult to appointment time, and decreased average total appointment time. These improvements may lead to improved resource utilization and management in a large public county safety net hospital setting.

This is a 2020 ARVO Annual Meeting abstract.

 

Table 1. Patient demographics and other characteristics

Table 1. Patient demographics and other characteristics

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×